First Trust Advisors LP Adma Biologics, Inc. Transaction History
First Trust Advisors LP
- $108 Billion
- Q4 2024
A detailed history of First Trust Advisors LP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 333,309 shares of ADMA stock, worth $6.14 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
333,309
Previous 561,228
40.61%
Holding current value
$6.14 Million
Previous $11.2 Million
49.05%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$344 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$335 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$274 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$208 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$102 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.62B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...